Related Experiment Video
Updated: Jul 12, 2025

19:53
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
105.9K
Myasthenia Gravis Presenting as Bulbar Palsy
1General Internal Medicine, Peterborough City Hospital, Peterborough, GBR.
Cureus
|October 30, 2023
Summary
Myasthenia gravis, a rare autoimmune disorder affecting muscle receptors, can present unusually as bulbar palsy. Early diagnosis and treatment are crucial for managing this condition and preventing complications.
Area of Science:
- Neurology
- Immunology
- Autoimmune Diseases
Background:
- Myasthenia gravis (MG) is a rare autoimmune disorder impacting neuromuscular junctions.
- It primarily targets postsynaptic cholinergic receptors, leading to muscle weakness and fatigue.
- Variable clinical presentations can complicate diagnosis, often resulting in delayed identification.
Observation:
- A patient in her 30s presented with symptoms mimicking bulbar palsy, a rare manifestation of MG.
- The patient experienced significant risk of silent aspiration due to delayed diagnosis.
- Ocular symptoms are more common in MG, making bulbar presentation less typical.
Findings:
- The patient was diagnosed with generalized myasthenia gravis and a concurrent thymoma.
- Diagnostic workup confirmed the autoimmune nature and specific receptor involvement.
- The bulbar palsy presentation was a key diagnostic challenge.
Implications:
- This case highlights the importance of considering rare MG presentations like bulbar palsy.
- Prompt diagnosis and management, including pyridostigmine, corticosteroids, and immunoglobulins, are vital.
- Surgical intervention (thymectomy) is a planned part of the treatment strategy for thymoma-associated MG.
- Timely intervention can significantly reduce morbidity and mortality in myasthenia gravis patients.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Disorders of the Skeletal Muscle
968
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
968
Myasthenia Gravis: Diagnostic Tests
924
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
924
Chemical Synapses
8.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.9K
Skeletal Muscle Relaxants: Therapeutic Uses
493
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
493
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567

